Overview Corneal Collagen Cross-Linking for Ectasia (CXL) Status: Completed Trial end date: 2011-11-01 Target enrollment: Participant gender: Summary Prospective, randomized multicenter study to determine the safety and effectiveness of performing corneal collagen cross-linking (CXL) using riboflavin and UVA light in eyes with ectasia after refractive surgery. Phase: Phase 3 Details Lead Sponsor: Avedro, Inc.Glaukos CorporationTreatments: Ophthalmic SolutionsPharmaceutical SolutionsRiboflavin